Browse Contents
Select Volume:  

Select Issue:  

Select Article:


Special Offers






Abstracted/Indexed in




Endorsements

"In view of the growing volume of literature, the role of high quality review journals has become increasingly important. Current Drug Targets is an important journal in the field of medicinal chemistry and drug design, which is strongly recommended to the scientific community."

Jean-Marie Lehn
Nobel Laureate

Forthcoming Special Issues

Nanotechnology in biomedical applications


Guest Editor(s): Teresa Puig, Joaquim Ciurana
Tentative Publication Date: April, 2019
Submit Abstract via Email Download Description
Published Special Issues

Bone drug targets


Current Drug Targets, Volume 19, Number 05
Guest Editor(s): Crispin R. Dass

Authors' Comments
It was a nice experience to publish our article in current drug target. I felt that the journal is quick and has maintained very high standard by independently reviewing article from more than five reviewers. The communication between the author and the Journals editorial is also speedy. I hope the journal will continue to maintain and sustain its reputation

Pushpender K. Sharma
(Department of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Pb, India)


Current Drug Targets

,

Volume 19

-

Number 6



Review Article





Review Article

To Bleed or Not to Bleed: That is the Question. The Side Effects of Apixaban

, 19(6): 581 - 584

Marco Matteo Ciccone*, Annapaola Zito, Fiorella Devito, Maria Maiello and Pasquale Palmiero


DOI: 10.2174/1389450116666151001113932






Review Article

New Advances in Atrial Fibrillation Management: The Role of Apixaban

, 19(6): 585 - 592

Giuseppe M.C. Rosano, Ilaria Spoletini, Walter Gianni and Cristiana Vitale*


DOI: 10.2174/1389450118666171013095413






Review Article





Review Article





Review Article

Drug Resistance of Enzalutamide in CRPC

, 19(6): 613 - 620

Xuedong Chen, Jieyang Lu, Liqun Xia and Gonghui Li *


DOI: 10.2174/1389450118666170417144250






Review Article





Review Article





ApoE4 May be a Promising Target for Treatment of Coronary Heart Disease and Alzheimer's Disease


Wei Chen*, Fengzhong Jin, Guihua Cao, Rong Mei, Yayun Wang, Pan Long, Xiaoming Wang and Wei Ge


View Abstract View on PubMed


New Light on An Old Friend: Targeting PUMA in Radioprotection and Therapy of Cardiovascular and Neurodegenerative Diseases


Ales Tichy, Jan Marek, Radim Havelek*, Jaroslav Pejchal, Martina Seifrtova, Lenka Zarybnicka, Alzbeta Filipova, Martina Rezacova and Zuzana Sinkorova


View Abstract View on PubMed


Why Methylene Blue Have to Be Always Present in the Stocking of Emergency Antidotes


Caroline Floreoto Baldo, Luiza Mateus Silva, Livia Arcencio, Agnes Afrodite Sumarelli Albuquerque, Andrea Carla Celotto, Anibal Basile-Filho and Paulo Roberto B Evora*


View Abstract View on PubMed


Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm


Koichi Yoshimura*, Noriyasu Morikage, Shizuka Nishino-Fujimoto, Akira Furutani, Bungo Shirasawa and Kimikazu Hamano


View Abstract View on PubMed


Nanoparticles in Cancer Treatment: Opportunities and Obstacles


Rajendra Awasthi*, Ariane Roseblade, Philip Michael Hansbro, Michael John Rathbone, Kamal Dua and Mary Bebawy


View Abstract View on PubMed


New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention


Patrycjusz Kolodziejczyk, Anna Gromotowicz-Poplawska, Michal Aleksiejczuk, Ewa Chabielska, Piotr Tutka and Wojciech Miltyk*


View Abstract View on PubMed


The Molecular Targets of Swertiamarin and its Derivatives Confer Anti-Diabetic and Anti-Hyperlipidemic Effects


Naisargee Patel*, Rajeev Kumar Tyagi, Nikunj Tandel, Neeraj Garg and Nupur Soni


View Abstract


Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma

, 2018; 19(5): 409 - 421

Zhengxiao Ouyang, Haowei Li, Zanjing Zhai, Jiake Xu, Crispin R. Dass, An Qin* and Kerong Dai*


DOI: 10.2174/1573399811666150615145409



Smart Triggered Release in Controlled Drug Delivery

, 2018; 19(4): 318 - 327

Paul Catalin Balaure, Dragos Gudovan* and Iulia Alexandra Gudovan


DOI: 10.2174/1389450117666160401125034



Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science